TNF and autoimmune disease: Many TNF-α antagonists, icluding Infliximab, Certolizumab, Etanercept, Golimumab, and Adalimumab have revolutionized for therapeutic management of different autoimmune diseases, notably rheumatologic inflammatory diseases6–10.